Cadrenal Therapeutics, Inc. earnings per share and revenue

CVKD earnings per share for the last quarter are -2.18 USD whereas the estimation was -1.93 USD which accounts for -13.15% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -2.02 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of CVKD earnings per share and revenue dynamics.